Buy & Sell S&P Global Inc (SPGI) – S&P Global Inc Price Today
Aura AI Summary
Key Stats
- $123.06BMarket Cap
- FinancialsSector
- -10.88%3M Drawdown
- $135.02BEnterprise Value
- 0.93%Dividend Yield
- 71% Buy | 29% SellTrading Activity
- 110 daysTypical Hold Time
S&P Global Inc (SPGI) is currently valued at a market capitalization of $123.06B, with an enterprise value of $135.02B. Over the past 52 weeks, S&P Global Inc has traded between a low of $390.76 and a high of $564.15, highlighting its annual price range. Over the past three months, S&P Global Inc has recorded a drawdown of -10.88%, reflecting recent price volatility. S&P Global Inc offers a dividend yield of 0.93%, with the most recent dividend of $0.97 paid on 25 Feb 26. On average, investors hold S&P Global Inc for approximately 110 days, indicating typical investor behavior on the platform.
About S&P Global Inc
S&P Global provides data and benchmarks to capital and commodity market participants. In 2021 and excluding IHS Markit, S&P Ratings was over 45% of the firm's revenue and over 55% of the firm's operating income. S&P Ratings is the largest credit rating agency in the world. The firm's other segments include Market Intelligence, Indices, and Platts. Market Intelligence provides desktop tools and other data solutions to investment banks, corporations, and other entities. Indices provides benchmarks for financial markets and is monetized through subscriptions, asset-based fees, and transaction-based royalties. Platts provides benchmarks to commodity markets, principally petroleum.
Most Recent News
Calidi Biotherapeutics discloses NYSE-required audit note on going concern status in 2025 financial report.
Calidi Biotherapeutics announced that its 2025 Annual Report included an audit report with an explanatory paragraph highlighting the assumption that the company will continue as a going concern. This disclosure is mandated by the NYSE American Compan...

Oura's IPO tests if wellness tech can thrive in public markets amid shifting digital health trends.
Oura Health is preparing for an IPO that could indicate whether public markets are ready to support consumer-focused digital health companies. Unlike earlier wearables focused on hardware sales, Oura emphasizes a subscription model offering health in...

Meta's $125B AI investment sparks investor concern amid rising costs and layoffs
Meta has raised its 2026 capital expenditure guidance to $125-$145 billion, nearly five times last year's $28 billion, focusing heavily on AI infrastructure. Despite strong ad revenue growth, investors worry about the lack of clear AI-driven monetiza...
